Osaka University researchers base biomarker detection and targeted therapy on the same protein from pancreatic cancer patients Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, […]Continue Reading ...
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers. The University of Texas MD Anderson Cancer Center […]Continue Reading ...
The Henry Ford Cancer Institute announced today it has enrolled the first patient in a new clinical trial to test the effectiveness of using precise, higher dose MRI-guided radiation therapy to treat pancreatic cancer. Prior analysis has shown that MRI-guided radiation therapy may be a promising therapy for treating locally advanced pancreatic cancer. This suggests […]Continue Reading ...
The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced […]Continue Reading ...
Nov 15 2018 Pancreatic cancer death rates in the European Union (EU) have increased by 5% between 1990 and 2016, a report launched today reveals. This is the highest increase in any of the EU’s top five cancer killers which, as well as pancreatic cancer, includes lung, colorectal, breast and prostate cancer. Number of Pancreatic […]Continue Reading ...
You’re experiencing jaundice, abdominal pain or constipation. And by then, you may be too late. Pancreatic cancer symptoms often arrive after the cancer has already spread, making the disease one of the leading causes of cancer deaths in the U.S. However, a team of researchers believes that targeting how blood clots form and are naturally […]Continue Reading ...
A new approach to treating pancreatic cancer using ‘educated killer cells’ has shown promise, according to early research by Queen Mary University of London. The new cell-based immunotherapy, which has not yet been tested in humans with pancreatic cancer, led to mice being completely cancer-free, including cancer cells that had already spread to the liver […]Continue Reading ...
LYON, France and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) — Erytech Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that the first three patients have been enrolled in its pivotal Phase 3 clinical trial, named ‘TRYbeCA1’, evaluating its […]Continue Reading ...
Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers. The University of Texas MD Anderson Cancer Center research team found overexpression of the immune checkpoint VISTA on immune cells, especially macrophages, that […]Continue Reading ...
A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how. The long-held view that the islets of Langerhans can be replenished from pancreatic stem cells (progenitors) was replaced over the last decade by the notion that islets self-duplicate from existing cells. Now, in […]Continue Reading ...
Research on a new way of deploying the immune system against pancreatic cancer, an exceptionally lethal cancer that has so far resisted new immunotherapies, will receive $1 million in initial funding from Stand Up to Cancer. The project led by researchers from The University of Texas MD Anderson Cancer Center and Baylor College of Medicine […]Continue Reading ...
New research has linked adolescent obesity with up to a four-fold increased risk of pancreatic cancer later in life. The study’s results also suggest that overweight and even higher weight within the “normal” weight range in men may increase pancreatic cancer risk in a graded manner. The findings are published early online in CANCER, a […]Continue Reading ...
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center – Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma (PDAC), the […]Continue Reading ...
In a new study from Lawson Health Research Institute and Western University’s Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females. The study marks the first time a sex-specific genetic risk factor for pancreatic cancer […]Continue Reading ...
Pancreatic cancer is currently very difficult to detect while it is still resectable. A new blood test developed by researchers at Lund University in Sweden, Herlev Hospital, Knight Cancer Center and Immunovia AB, can detect pancreatic cancer in the very earliest stages of the disease. The results have been published in the Journal of Clinical […]Continue Reading ...
- Neuroscientists show how the brain responds to texture
- Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
- What Can I Do About Sweating? (for Teens)
- Companies navigate dementia conversations with older workers
- Newly developed stem cell technologies show promise for treating PD patients
- Collaborative material research could advance self-assembling nanomaterials
- Researchers take major step in creating technology that mimics the human brain
- Erasing memories associated with cocaine use reduces drug seeking behavior
- Artificial intelligence can accurately predict prognosis of ovarian cancer patients
- Racial disparities in cancer deaths on the decline for America
- FDA authorizes new interoperable insulin pump for children, adults with diabetes
- Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link
- Skin Cancer Screening: MedlinePlus Lab Test Information
- ‘Happiness’ exercises can boost mood in those recovering from substance use disorder
- Cell manipulation could soon halt or reverse aging
- Pumped Breast Milk Falls Short of Breastfed Version
- Men’s porn habits could fuel partners’ eating disorders, study suggests
- Rapid progression of age-related diseases may result from formation of vicious cycles
- Immune checkpoint molecule protects against future development of cancer
- New method produces hydrogels that have properties similar to cells’ environment